Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NEL, dynaCERT, K+S: Where analysts see 280% potential

Innovative technology brings returns to investors. The best example is the share of the Norwegian hydrogen specialist NEL. In the past twelve months, the value has increased by more than 250%. The reason: The mobility revolution is underway and many experts see hydrogen as the...
Nico Popp | January 13, 2021 |

Positive Cash Flow Extractor Manufacturer Turns its Mind to Psychedelics

“It’s all about visibility.” That’s how Calgary, AB-based MedXtractor Corp. (MXT) ( CSE.MXT , Forum ) is changing both the future of cannabis extraction and the burgeoning mental health science of psychedelics. ...
Dave Jackson | January 15, 2021 |

BASF and Cardiol Therapeutics recommended buys; TUI rides momentum

BASF (OTCQX:BASFY) shares have gained over 30% within six months. But is the rally in BASF shares slowly running out of steam? The fact that the stock did not rise sharply yesterday despite a significant price target increase suggests this is the case. Many experts see ...
Fabian Lorenz | April 10, 2024 |

Aurora Cannabis, Canopy Growth, EXMceuticals - who will be the best turnaround story?

Cannabis shares are not in demand at the moment. About a year ago the growth potential and possibilities of the rediscovered historical medicinal plant seemed to be endless. Today it is different, there is a hangover mood. The hype back then led to a buyer's market. Investors ...
Mario Hose | February 25, 2020 |

April 15th 2020, Crypto Chartbook: Evolve or die

Evolve or die That might be too strong a title, but it’s not! The law of evolution is principle based, saying that adoption is required especially in times of rapid change. It is without a question such a time. For example, a successful carburetor spe...
Korbinian Koller | April 15, 2020 |

Ballard Power, NVIDIA, SolGold - copper, processors and fuel cells for the portfolio

The mobility of the future will be diverse. In addition to internal combustion engines, vehicles with electric motors will also define future everyday life. This politically motivated development will be supported by subsidies and premiums in various areas. Investors who would...
Mario Hose | August 27, 2020 |

Research In Motion (RIMM) stock vulnerable to more selling

Continued improvement in the global economy helped propel Wall Street to rather impressive gains last year. The Dow Jones Industrial Average (DJIA) added 18.8% for the year, while the S&P 500 Index (SPX) vaulted some 23.5% higher. The Nasdaq Composite (COMP), however, put it...
Joseph Hargett | October 28, 2012 |

NetApp (NTAP) suffering from low earnings expectations

The computer hardware sector has been an outperformer during the past year, with the NYSE Arca Computer Hardware Index ( HWI ) soaring more than 87% during the prior 52 weeks. Comparatively, the tech-laden, and market-leading, Nasdaq Composite (COMP) has rallied some 48% dur...
Joseph Hargett | October 28, 2012 |

IVERIC bio Shares Double After Announcing Phase 2b AMD Topline Data

Shares of IVERIC bio opened nearly 100% higher today after reporting that it successfully met its primary endpoint in its Phase 2b age-related macular degeneration study for Zimura. Early this morning, gene therapy focused biopharmaceutical company IVERIC bio Inc. (I...
Streetwise Reports | October 29, 2019 |

Gold Could Be Trending Higher Against the Dow

The Dow/Gold ratio broke a trend-line in past few weeks that could be signaling that gold could be trending higher against the Dow Jones Industrial Index in the next 18 months to two years. An example might be a ratio of 10 or the Dow at 20,000 and gold at $2,000 (a new...
Streetwise Reports | March 12, 2020 |
1 2 3 4 5 6 7 8